Celltrion Inc

KR

ORCHE

Health Care

178700 ₽

Current price

Sell
178700 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    375 / 1361

  • Position in country

    1679 / 2780

  • Return on Assets, %

    8.6

    -40.3

  • Net income margin, %

    0.1

    -180

  • EBITDA margin, %

    24

    -168.2

  • Debt to Equity, %

    11.1

    3.2

  • Intangible assets and goodwill, %

    66.9

    0.2

  • Revenue CAGR 3Y, %

    5.5

    12.5

  • Total Equity change 1Y, %

    299.6

    -9

  • Revenue Y, % chg

    -6.1

    0

  • P/E

    48.4

    31

  • P/BV

    2.2

    1.8

  • P/S

    18.2

    10.3

  • EV/S

    19

    7.5

  • EV/EBITDA

    45.9

    -1.6

  • Average Analyst recommendation

    Buy

    Buy

  • Average upside forecasts, %

    24.9

    131.1

  • Forward P/E

    38.8

    21.4

  • Dividend Yield, %

    0.2

    1.1

  • Forward Dividend Yield, %

    0

    0.1

  • Expected dividend per share

    0.3

    0

  • Payout Ratio, %

    19.3

    0

  • Dividend Ex Date

    2023-12-27

Get an analytical review of this company

Competitors

Ranks

  • PharmaResearch Co Ltd

    00%

  • Hugel Inc

    00%

  • Amgen Inc

    00%

  • Celltrion Inc

    00%

  • Seegene Inc

    00%

  • Alteogen Inc

    00%

  • GC Biopharma Corp

    00%

  • ABL Bio Inc

    00%

  • AbbVie Inc

    00%

  • SK Bioscience Co Ltd

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    Korea; Republic (S. Korea)

  • Sector

    Health Care

  • Industry group

    Pharmaceuticals, Biotechnology & Life Sciences

  • Industry

    Biotechnology

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    29062.4

  • Ticker

    068270.KS

  • ISIN

    KR7068270008

  • IPO date

    2005-07-19

  • Availability on Russian exchanges

    No

  • Reporting for

    2024-03-18

  • Date fact. publication of reports

    2023-12-31

Company Description

Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.